Revenue growth masks profitability squeeze; execution risk on ambitious FY30 targets
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
First-time earnings call reviewed; no prior guidance miss/hit data available from transcript. CFO acknowledged WC headwind and WIP timing as structural; PAT decline attributed to finance costs and WIP pause before Mar recognition.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Solid 16% revenue growth offset by 1.7% PAT decline and structural negative operating cash flow signal execution challenges. Order book visibility (₹806.80 Cr, ₹473.86 Cr unexecuted) is a strength, but margin compression and WC cycle risk warrant caution. Long-term ₹900–1,000 Cr FY30 target credible given government infrastructure tailwinds and PSU relationships (90% revenue), but delivery track record unproven.
₹70.72 Cr
Revenue · +16.01% YoY₹6.25 Cr
Reported PAT · −1.71% YoYCompressing
Margins · vs guidance: UnverifiedDid the claims hold up?
Revenue growth 16% YoY to ₹70.72 Cr
MET₹70.72 Cr vs ₹60.96 Cr H1 FY26 = 16.01% confirmed
EBITDA grew 10.29% to ₹13.60 Cr
MET₹13.60 Cr vs ₹12.33 Cr = 10.29% confirmed
PAT stood at ₹6.25 Cr, marginal decline 1.71%
MET₹6.25 Cr vs ₹6.36 Cr = -1.71% confirmed
EBITDA margin impact minor, ~0.1%
OVERSTATEDH1 FY26 EBITDA margin ~20.24% (₹12.33/₹60.96), H1 FY27 ~19.21% = ~103 bps compression, not 0.1%
Order book ₹806.80 Cr with ₹473.86 Cr unexecuted
METStated as Nov 2026 position; unexecuted = 58.7% of total book = reasonable visibility
90% revenue from PSU/government, 70% repeat rate
METStated directly; no contradicting evidence
Earnings quality
What changed since the last call
Geographic ambition elevated
UpgradeNow targeting pan-India presence (Gujarat, MP, UP, Tripura, Assam) vs regional Northeast focus. Private sector (GFL, BCPL, Chatterjee) now in scope, not just PSU.
Order book expansion rate accelerated
UpgradeTargeting ₹200 Cr (FY27) → ₹500 Cr (FY28) → ₹1,000 Cr (FY29) in additions. Implies portfolio CAGR ~30%+. Prior year call not referenced; assumed acceleration is new.
Margin pressure emerging
DowngradeEBITDA margin compressed ~103 bps YoY (20.24% → 19.21%); PAT down 1.7% despite 16% revenue growth. Finance costs and WIP timing cited, but underlying issue real.
Cash flow narrative reframed
NeutralOCF -₹5.69 Cr explained as structural EPC characteristic, not emergency. CFO claims 1–2 year timeline to positive CF; acknowledged as 'working capital will take more than a year or two' for stabilization.
The Q&A
Analysts pressed on WC (Ayan), margin compression (Maitri), and private sector capacity (Maitri). Management answered directly with WC mechanics, acknowledged 0.1% margin drop (understated; actual ~103 bps), and detailed financing options (structured debt, joint ventures) to avoid equity dilution. No evasion; tone was measured but confident on market opportunity.
Working capital management — Ayan, Heritage
AnsweredReserves and surplus cover current execution; future expansion via debt and structured financing. Planning ₹200 Cr order adds FY27 via project cash flow; further expansion via capital raise if needed.
Tender pipeline & order inflows — Ayan, Heritage
Answered₹500 Cr bids outstanding; expecting ₹100 Cr by December and ₹100 Cr by March 2027. Planning ₹500 Cr additional bids for next cycle.
Operating cash flow — Ayan, Heritage
AnsweredCFO: Structural EPC characteristic. 60% of sales in Feb–Mar creates year-end receivable spike. Inventory and vendor advances inflate current WC. Claims positive CF in 1–2 years once sales stabilize. No credit risk as 90% from PSU.
Competitive positioning — Ayan, Heritage
AnsweredMD: Below ₹300 Cr, 8–9 players; above, only 3–4 (Kalpataru, L&T, KEC). Oval is engineer-driven, not typical EPC. Market capacity-constrained post-Hormuz; big players can't absorb all jobs. Oval participates upstream, midstream, downstream sectors.
Private sector diversification — Maitri Shah, Sapphire
AnsweredMD: In advanced discussions with GFL (5 LiB electrolyzer plants Gujarat/UP), Chatterjee International (oil & gas expansion South), BCPL (₹11,000 Cr fertilizer expansion Assam). Also targeting fertilizer sector to leverage gas expertise.
Private order size & funding capacity — Maitri Shah, Sapphire
PartialMD: ₹200–300 Cr+ jobs require market funding. Exploring structured debt, project finance, joint ventures with partners. Wants to retain 51%+ equity; not diluting. Slow growth strategy: ₹200 Cr adds FY27, ₹500 FY28, ₹1,000 FY29 to maintain 30% YoY growth.
EBITDA margin decline — Maitri Shah, Sapphire
PartialCFO: Minor 0.1% drop (note: actual ~103 bps). UWIP on books to be booked Feb–Mar (paused now). Upfront mobilization and finance cost higher, impacting PAT; EBITDA increased but PAT nominally decreased.
Storage expansion opportunity — Maitri Shah, Sapphire
AnsweredMD: Hormuz incident was 6 months ago; government planning storage allocation in next budget. Small projects in progress (e.g., APL methanol storage ₹150 Cr Gujarat). Government investing ₹84,390 Cr in Samudra Manthan (deep-sea), ₹23,770 Cr biogas; expects huge storage investment next budget.
Bidding pipeline detail — Priya Shah, Minyara
AnsweredMD & Director Sneha: FY27 target ₹200 Cr adds from Gujarat area projects, CBG projects (ONGC), water infrastructure, ADB/World Bank Tripura. Specific bids: water supply Agartala ₹150 Cr, ONGC cathodic protection + firefighting (Gujarat, Andhra Pradesh), IGDL 2nd phase (₹3,000 Cr investment), RTP pipeline 500 km (ONGC assets).
Guidance
FY27 order book additions: ₹200 Cr (₹100 Cr Dec, ₹100 Cr Mar)
High₹500 Cr tender pipeline bid; specific projects identified (Gujarat, ONGC, water Agartala). Conservative add rate consistent with disciplined execution.
FY30 revenue target: ₹900–1,000 Cr (multi-year ambition)
MediumSupported by geographic expansion (Western India, Assam), larger project capacity, private sector diversification. Implies CAGR ~10–12% from H1 FY27 ₹70.72 Cr annualized (~₹141 Cr). Subject to project awards, execution, market conditions (MD's caveat).
EBITDA margin: maintain ~19–20% (current ~19.21%)
MediumCFO claims 0.1% drop (actual ~103 bps); attributes to WIP timing. No explicit FY27/FY30 margin target stated; underlying cost pressure from finance headwind not fully quantified.
Risks the call surfaced
Customer concentration
Medium90% of revenue from PSU/government (ONGC, IOC, GAIL, IOCL). Single customer or sector slowdown (e.g., refining, gas) could halve revenue. Mitigation in progress but private sector not yet converted.
Working capital cycle
High60% of annual sales recognized in Feb–Mar; creates year-end receivable spike and -₹5.69 Cr H1 OCF. Advances to vendors add inventory burden. CFO estimates 1–2 years to positive OCF; lumpy cash generation constrains growth capex and debt servicing.
Profitability erosion
MediumH1 PAT declined 1.7% YoY despite 16% revenue growth. EBITDA margin compressed ~103 bps (CFO claimed 0.1%, understated). Finance costs higher; WIP deferral impacting recognition. Suggests underlying cost inflation or lower-margin project mix.
Execution risk on expansion
MediumPlan to scale order book ₹200 Cr (FY27) → ₹1,000 Cr (FY29) implies 30% CAGR. Private sector (GFL, BCPL, Chatterjee) still in discussions, not converted. Western India expansion (Gujarat, MP, UP) unproven; no track record mentioned. Larger projects require stronger WC management and execution discipline.
Government/policy sensitivity
LowStorage expansion opportunity dependent on next government budget allocation (Hormuz incident only 6 months old). IGDL 2nd phase, Samudra Manthan, biogas investments subject to government priorities. Tender slippage or repriorization could delay order inflows.
Management
Score 7/10. Clear and detailed. CFO explained WC mechanics thoroughly without evasion. MD provided concrete competitive positioning and market analysis. Sneha Banik specific on bidding details. Some hedging on private sector quantum ('depends on capital'), but justified by execution constraints. Track record: 90+ projects completed, 1,200+ km pipelines, 13 years established. H1 PAT declined 1.7% YoY despite 16% revenue growth—suggests execution challenges (WIP timing, cost control). Repeat order rate 70% indicates operational credibility with existing customers; new sector/geographic expansion unproven.
1 · Dec 2026 – Mar 2027
₹100 Cr orders each quarter expected (tenders already bid, ₹500 Cr pipeline)
2 · Q4 FY27 (Feb–Mar 2027)
Q3 results will show higher revenue (60% of annual sales in Feb–Mar); UWIP to be recognized
3 · FY28
GFL lithium-ion battery electrolyzer expansion (5 plants Gujarat/UP) potential orders
Long-term ₹900–1,000 Cr FY30 target credible given government infrastructure tailwinds and PSU relationships (90% revenue), but delivery track record unproven.
Growth Masking Profit Stress; Execution on 30% Expansion Targets Unproven
Revenue shot up 16% but profit fell 1.7%. The gap—working capital, WIP timing, and finance costs—is structural, not temporary. Order book strength masks real execution friction on ambitious plans.
₹70.72 Cr
+16% YoY
₹6.25 Cr
-1.7% YoY
₹13.60 Cr
+10.3%, margin -103 bps
-₹5.69 Cr
WC cycle drag
Oval Projects turned in a paradoxical quarter: revenue climbed a healthy 16% to ₹70.72 Cr, yet profit fell 1.7% to ₹6.25 Cr. On the surface, that's confusing. But the friction is real—and it's structural, not cyclical. The order book grew, the repeat customer rate held at 70%, and management is confident on ₹900–1,000 Cr FY30 ambitions. Yet beneath the top-line strength lies a company wrestling with three headwinds: working capital collapse (OCF -₹5.69 Cr), profit recognition deferred to Q4 via WIP mechanics, and a finance cost burden that's rising as leverage climbs. This is growth with real execution questions.
Where the profit gap came from
EBITDA grew 10.3% to ₹13.60 Cr, but PAT fell 1.7% to ₹6.25 Cr. The gap between EBITDA growth and profit decline is the story. CFO claimed the EBITDA margin impact was 'minor, 0.1%'—but the actual compression is ₹103 bps (20.24% in H1 FY26 to 19.21% in H1 FY27). Three factors explain it:
Revenue +16% YoY to ₹70.72 Cr
₹70.72 Cr vs ₹60.96 Cr = 16.01% confirmed
Supported
EBITDA grew 10.29% to ₹13.60 Cr
₹13.60 Cr vs ₹12.33 Cr = 10.29% confirmed
Supported
PAT ₹6.25 Cr, marginal 1.71% decline
₹6.25 Cr vs ₹6.36 Cr = -1.71% confirmed
Supported
EBITDA margin impact 'minor, ~0.1%'
20.24% (H1 FY26) → 19.21% (H1 FY27) = ~103 bps compression
Overstated (downplayed severity)
Order book ₹806.80 Cr with ₹473.86 Cr unexecuted
Nov 2026 snapshot; 58.7% of book unexecuted = reasonable visibility
Supported
90% revenue from PSU/government, 70% repeat rate
Stated directly; no contradicting data
Supported
What changed on this call
Geographic and sectoral ambition shifted materially. Until now, Oval was a Northeast-focused, PSU-reliant EPC house. On this call, management outlined a pan-India pivot: Gujarat, Madhya Pradesh, Uttar Pradesh, Tripura, Assam. More significant, private sector diversification is now central—advanced discussions with GFL (lithium-ion battery electrolyzer, 5 plants Gujarat/UP), BCPL (₹11,000 Cr fertilizer expansion Assam), and Chatterjee International (oil & gas South). These are not yet closed, but they signal a strategic reorientation away from pure PSU dependency (currently 90% of revenue). Order book growth targets accelerated sharply. Management now targets ₹200 Cr order additions in FY27 (₹100 Cr by Dec, ₹100 Cr by Mar), ₹500 Cr in FY28, and ₹1,000 Cr in FY29. That's a 30% CAGR on order inflow, backed by a ₹500 Cr tender pipeline bid. Prior-year guidance on this cadence was not disclosed, so the acceleration is new. Margin pressure acknowledged, but severity minimized. CFO claimed the EBITDA margin drop was 0.1%—when it's actually 103 bps. This is not deception, but tone-deaf to the magnitude and suggests limited accountability. The underlying friction (WIP timing, finance costs, project mix) is real and unresolved.
The bull-bear ledger
Order book strength: ₹806.80 Cr total, ₹473.86 Cr unexecuted = 2+ years of visibility at current run rates
Execution credibility: 90+ projects completed, 1,200+ km pipelines in 13 years; 70% repeat order rate signals PSU trust
Government tailwind: Energy security agenda (refining expansion, gas production, storage, biogas) is structural and multi-year
Profit fell 1.7% despite 16% revenue growth—execution friction is real, not just WIP timing
Working capital cycle structurally negative: -₹5.69 Cr OCF. CFO estimates 1–2 years to positive CF. This constrains capex and growth debt capacity.
Margin compression (~103 bps YoY) persists despite PSU tailwind; suggests lower-margin project mix or cost inflation
Finance cost headwind unnamed but acknowledged; leverage rising as order book scales and WC normalizes later
Private sector conversions (GFL, BCPL, Chatterjee) still in discussions; not yet closed. Timing and quantum speculative.
Customer concentration: 90% PSU/government. Single sector slowdown (refining, gas) or tender freeze could cut revenue in half
₹1,000 Cr FY29 order additions = 30% CAGR on inflow. Unproven at scale; execution risk is medium-to-high.
Risks, ranked by how much they should concern a holder
Negative operating cash flow; 1–2 year normalisation horizon
HighOCF -₹5.69 Cr despite ₹70.72 Cr revenue. 60% of sales in Feb–Mar creates year-end receivable spike. Inventory and vendor advances compound it. CFO claims structural EPC cycle and will turn positive once sales stabilize—but 1–2 years of funding pressure on capex, debt service, and growth spend is real. PSU receivable risk is low (90% on-time), but cash timing friction constrains optionality.
Profitability erosion via margin compression + finance costs
HighEBITDA margin down 103 bps YoY; PAT down 1.7% despite 16% revenue growth. Finance cost headwind is unnamed but real. As order book scales and WC unwinds, leverage will rise. If margin compression continues, profit growth will stall or reverse. H1 PAT at ₹6.25 Cr is not sustainable if this is the new baseline; Q4 must prove recovery via WIP recognition.
Customer concentration; 90% PSU/government
MediumSingle sector slowdown (oil refining, gas production, government spending cut) could halve revenue overnight. Repeat order rate (70%) suggests stickiness within PSU base, but diversification is urgent. Private sector deals (GFL, BCPL) not yet closed. Risk mitigates if private orders close, but execution timeline is Q4 FY27 at earliest.
Execution on 30% order inflow CAGR (₹1,000 Cr FY29 target); private sector new
MediumPlan to grow order additions from ₹200 Cr (FY27) → ₹500 Cr (FY28) → ₹1,000 Cr (FY29) is aggressive and implies portfolio expansion into larger projects and new private sectors (GFL, BCPL). Oval has executed well at smaller scale (₹300 Cr projects and below); track record at ₹500+ Cr scale is unproven. Finance cost burden will rise; WC discipline will be tested.
Work-in-progress deferral creates earnings volatility
Medium60% of annual sales and profit in Q4 (Feb–Mar) means Q1/Q2/Q3 results are lumpy and not representative of run-rate. ₹150+ Cr WIP currently paused will be recognized in Q4, boosting Feb–Mar numbers artificially. Investors cannot reliably forecast quarterly results; must focus on full-year trends and order book.
PSU receivable delays; government budget cycles
Low90% of revenue from PSU (on-time payment confirmed), so credit risk is negligible. But government budget allocation cycles and tender timing can slip (e.g., storage expansion opportunity depends on next budget). Multi-sector exposure (refining, gas, fertilizer, water) hedges single-policy risk.
How the street is positioned
The stock is priced at ₹45 as of 2026-11-09, down 47.67% from its all-time high of ₹86. It sits below all key moving averages (SMA20 ₹44.09, SMA50 ₹47.8, SMA200 ₹54.43), just above its 52-week low of ₹40, and 12.5% up from lows. RSI 49.3 signals neutral momentum; volume is increasing, suggesting institutional interest but no clear directional conviction yet. Ownership has shifted modestly bearish. DII holdings fell 183 bps quarter-on-quarter (from 3.69% to 1.86%), while FII remained flat at 0.82%. Promoter holdings ticked up 5 bps to 53.12%—not a signal of insider strength. The DII trimming is notable; domestic institutions are lightening at a time when order book strength should attract them. This divergence—strong fundamentals (16% growth, ₹806.80 Cr order book) but institutions reducing exposure—suggests the street is skeptical of execution and cash flow normalization. The 47% drawdown from ATH reflects real concerns: the profit decline despite growth, negative OCF, and margin compression have eroded confidence. At current levels, the stock is pricing in continued execution challenges and a multi-year slog to normalize WC. Upside will require proof: (1) private sector order closes, (2) FY27 targets hit and ₹200 Cr orders materialize, and (3) Q4 results show WIP recovery and profit bounces back above H1.
The debate
1 · FY27 order inflow (Dec 2026 update expected)
Management targets ₹100 Cr new orders by December. With a ₹500 Cr tender pipeline bid and specific projects identified (Gujarat, ONGC, Agartala water ₹150 Cr), this is achievable. If orders come in on pace, confidence on ₹200 Cr FY27 and private sector pipeline will rise. Misses would flag tender competition or delays.
2 · Q4 FY27 profit recovery (Feb–Mar 2027 results)
CFO promised ₹150+ Cr WIP recognition in Feb–Mar and 60% of annual sales concentrated in Q4. If Q4 profits rebound materially (target: PAT ₹15–18 Cr for the quarter), the WIP timing story holds and full-year profit confirms management's narrative. If Q4 comes in flat or weak, structural profitability issues are real.
3 · Private sector order closes (FY28 forward)
GFL (5 LiB plants Gujarat/UP), BCPL (₹11,000 Cr Assam fertilizer), Chatterjee (South oil & gas) are all stated as in 'advanced discussions.' Any signed order or LOI is a material catalyst. These deals would prove diversification and reduce PSU concentration risk, unlocking valuation re-rating if margins stabilize.
The number to track
Adjusted PAT (ex-WIP timing, normalized CF). Reported H1 PAT of ₹6.25 Cr is not the true run-rate; it's depressed by WIP deferral and lumpy Q4-heavy revenue. Once working capital stabilizes and annual sales smooth out, normalized quarterly PAT should settle around ₹12–15 Cr (implying ₹48–60 Cr annual). If full-year FY27 PAT is ₹20–24 Cr (vs. ₹12–13 Cr implied by H1 at annualized run-rate), the quarter is delivering on management's WIP story. Below ₹18 Cr full-year is a warning that margin compression is structural.
Oval Projects is a credible, mid-tier EPC house with real order book strength and government tailwinds. But this quarter revealed the cost of its growth model: negative working capital, deferred profit recognition, and margin compression are structural, not noise. The stock's 47% drawdown from highs reflects legitimate execution skepticism. Management's confidence on ₹900–1,000 Cr FY30 revenue and ₹200 Cr FY27 order additions is not unreasonable, but delivery must be proven. The Q4 results and FY28 private-sector order closes are make-or-break catalysts. Until then, the stock remains a HOLD—safe on order book visibility, but not yet a re-rate candidate until profitability stabilizes.